Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modern Clinical Research on LSD
Matthias E. Liechti
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2114-2127
Open Access | Times Cited: 197

Showing 26-50 of 197 citing articles:

Dose–response relationships of psilocybin-induced subjective experiences in humans
Tim Hirschfeld, Timo Torsten Schmidt
Journal of Psychopharmacology (2021) Vol. 35, Iss. 4, pp. 384-397
Open Access | Times Cited: 67
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research
David A. Bender, David J. Hellerstein
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1907-1932
Closed Access | Times Cited: 64
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 876-917
Open Access | Times Cited: 55
Pattern breaking: a complex systems approach to psychedelic medicine
Inês Hipólito, Jonas Mago, Fernando E. Rosas, et al.
Neuroscience of Consciousness (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 39
Understanding the Mechanisms of Action and Effects of Drugs of Abuse
Daniela-Mădălina Ciucă Anghel, Gabriela Viorela Nițescu, Andreea Taisia Tiron, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4969-4969
Open Access | Times Cited: 25
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
Isabelle Straumann, Laura Ley, Friederike Holze, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 13, pp. 1840-1848
Open Access | Times Cited: 24
Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents
Erika Plazas, Nicoletta Faraone
Biomedicines (2023) Vol. 11, Iss. 2, pp. 461-461
Open Access | Times Cited: 22
The role of the methoxy group in approved drugs
Debora Chiodi, Yoshihiro Ishihara
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116364-116364
Closed Access | Times Cited: 14
A Hallucinogenic Serotonin-2A Receptor Agonist Reduces Visual Response Gain and Alters Temporal Dynamics in Mouse V1
Angie Michaiel, Philip R. L. Parker, Cristopher M. Niell
Cell Reports (2019) Vol. 26, Iss. 13, pp. 3475-3483.e4
Open Access | Times Cited: 75
Is LSD toxic?
David E. Nichols, Charles S. Grob
Forensic Science International (2018) Vol. 284, pp. 141-145
Closed Access | Times Cited: 74
Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)
David E. Nichols
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2331-2343
Closed Access | Times Cited: 73
Dark Classics in Chemical Neuroscience: Mescaline
Bruce K. Cassels, Patricio Sáez‐Briones
ACS Chemical Neuroscience (2018) Vol. 9, Iss. 10, pp. 2448-2458
Closed Access | Times Cited: 72
High dose psilocybin is associated with positive subjective effects in healthy volunteers
Christopher R. Nicholas, Kelsey M. Henriquez, Michele Gassman, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 7, pp. 770-778
Open Access | Times Cited: 71
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
Johannes G. Ramaekers, Nadia R. P. W. Hutten, Natasha L. Mason, et al.
Journal of Psychopharmacology (2020) Vol. 35, Iss. 4, pp. 398-405
Open Access | Times Cited: 69
Chemical warfare agents. Classes and targets
Michael Schwenk
Toxicology Letters (2017) Vol. 293, pp. 253-263
Closed Access | Times Cited: 68
Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains
Thomas F. Varley, Robin Carhart‐Harris, Leor Roseman, et al.
NeuroImage (2020) Vol. 220, pp. 117049-117049
Open Access | Times Cited: 68
Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD)
Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis (2019) Vol. 11, Iss. 8, pp. 1122-1133
Open Access | Times Cited: 67
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
Taylor Lyons, Robin Carhart‐Harris
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 67
Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
Dino Luethi, Matthias E. Liechti
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 10, pp. 926-931
Open Access | Times Cited: 61
The therapeutic potential of microdosing psychedelics in depression
Kim P. C. Kuypers
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 60
Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans
Alan K. Davis, Lynnette A. Averill, Nathan D. Sepeda, et al.
Chronic Stress (2020) Vol. 4
Open Access | Times Cited: 56
Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
Friederike Holze, Urs Duthaler, Patrick Vizeli, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 7, pp. 1474-1483
Open Access | Times Cited: 55
Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse
Marcus W. Meinhardt, Cansu Güngör, Ivan Skorodumov, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1316-1322
Open Access | Times Cited: 53
Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
Deborah Rudin, Matthias E. Liechti, Dino Luethi
Experimental Neurology (2021) Vol. 343, pp. 113778-113778
Open Access | Times Cited: 41
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
Emma I Kopra, Jason Ferris, James Rucker, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 956-964
Open Access | Times Cited: 32

Scroll to top